CRISPR–Cas: a tool for cancer research and therapeutics
Crossref DOI link: https://doi.org/10.1038/s41571-019-0166-8
Published Online: 2019-01-21
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yin, Hao
Xue, Wen http://orcid.org/0000-0002-9797-8042
Anderson, Daniel G.
Text and Data Mining valid from 2019-01-21
Article History
First Online: 21 January 2019
Competing interests
: H.Y., W.X. and D.G.A. have applied for CRISPR-related patents, one of which has been issued. D.G.A. is a scientific co-founder of CRISPR Therapeutics.